| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 4X6T64D64X |
Structure
| InChI Key | YCLREGRRHGLOAK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C19H20N2O2S |
| Molecular Weight | 340.45 |
| AlogP | 3.47 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 57.25 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 24.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Enoyl-[acyl-carrier-protein] reductase (FabI) inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Eczema | 2 | D004485 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL488937 |
| DrugBank | DB12347 |
| EPA CompTox | DTXSID00239434 |
| FDA SRS | 4X6T64D64X |
| Guide to Pharmacology | 10984 |
| PDB | PT6 |
| SureChEMBL | SCHEMBL2177308 |
| ZINC | ZINC000016696900 |
CONTENTS